Alnepezil (Donepezil Hydrochloride)

Donepezil hydrochloride is an acethylcholinesterase inhibitor indicated for the symptomatic treatment of dementia in Alzheimer’s disease. Used in patients with mild to moderately severe dementia and also for severe symptoms.

Dose

Mild to Moderate Alzheimer’s disease: 5mg to 10 mg once daily. Moderate to Severe Alzheimer’s disease: 10 mg to 25 mg once daily. A dose of 10 mg once daily can be administered once patients have been on a daily dose of 5 mg for 4 – 6 weeks. A dose of 25 mg once daily can be administered once patients have been on a dose of 10 mg once daily for at least 3 months.